BrightSpring Health Services Files Amendment to S-1 Registration Statement

TL;DR

<b>BrightSpring Health Services has filed an amendment to its S-1 registration statement, indicating progress towards a public offering.</b>

AI Summary

BrightSpring Health Services, Inc. (BTSGU) filed a Amended IPO Registration (S-1/A) with the SEC on January 25, 2024. BrightSpring Health Services, Inc. filed an amendment (S-1/A) to its registration statement on January 25, 2024. The filing is related to the Securities Act of 1933, with registration number 333-276348. The company's principal executive offices are located at 805 N. Whittington Parkway, Louisville, Kentucky 40222. The filing indicates BrightSpring Health Services is a non-accelerated filer. The proposed sale of securities is expected to commence as soon as practicable after the registration statement is declared effective.

Why It Matters

For investors and stakeholders tracking BrightSpring Health Services, Inc., this filing contains several important signals. This amendment signifies a step forward in BrightSpring Health Services' potential public offering, providing updated information to the SEC. The filing details the company's legal and administrative structure for the offering, including its agents for service and legal counsel.

Risk Assessment

Risk Level: low — BrightSpring Health Services, Inc. shows low risk based on this filing. The filing is an amendment to a registration statement, not a financial report, so specific financial risks are not detailed within this document.

Analyst Insight

Monitor future filings for details on the offering size, pricing, and financial performance of BrightSpring Health Services.

Key Numbers

• 333-276348 — Registration Number (Securities Act of 1933)
• 8082 — SIC Code (Home Health Care Services)
• 822956404 — IRS Number (Employer Identification No.)
• 2024-01-25 — Filing Date (Amendment No. 3 to FORM S-1)

Key Players & Entities

• BrightSpring Health Services, Inc. (company) — Registrant name
• 0001193125-24-015164 (other) — Accession Number
• 333-276348 (other) — Registration Number
• 805 N. Whittington Parkway, Louisville, Kentucky 40222 (location) — Principal executive offices
• Steven S. Reed (person) — Chief Legal Officer and Corporate Secretary
• Simpson Thacher & Bartlett LLP (company) — Legal counsel
• Latham & Watkins LLP (company) — Legal counsel
• January 25, 2024 (date) — Filing date

Forward-Looking Statements

• BrightSpring Health Services, Inc. will complete its IPO soon after this S-1/A is declared effective. (BrightSpring Health Services, Inc.) — high confidence, target: Q1 2024

FAQ

Industry Context

BrightSpring Health Services operates in the home health care services sector, a critical part of the healthcare industry focused on providing care in patients' homes.

Regulatory Implications

The filing is made under the Securities Act of 1933, which governs the registration of securities offerings in the United States.

What Investors Should Do

1. Review the full S-1/A filing for detailed disclosures regarding the offering.
2. Track subsequent SEC filings for updates on the registration statement's effectiveness and the offering's progress.
3. Analyze the company's business model and market position within the home health care industry.

Key Dates

• 2024-01-25: Filing of Amendment No. 3 to Form S-1 — Updates registration details for a potential public offering.

Year-Over-Year Comparison

This is an amendment to a previous filing, indicating ongoing activity related to a securities registration, rather than a comparison to a prior period's financial performance.

Key Financial Figures

• $835.8 million — ncurrent Offering will be approximately $835.8 million (or approximately $961.9 million if the
• $961.9 million — mately $835.8 million (or approximately $961.9 million if the underwriters exercise in full th
• $16.50 — ing an initial public offering price of $16.50 per share (which is the midpoint of the
• $15.00 — ice of our common stock will be between $15.00 and $18.00 per share. We have applied t
• $18.00 — common stock will be between $15.00 and $18.00 per share. We have applied to list our
• $2,400 — dication adherence and an approximately $2,400 per member per year reduction in total
• $1.0 — its combined market opportunity of over $1.0 trillion by starting with the projected
• $944 billion — d Medicare and Medicaid expenditures of $944 billion and $805 billion, respectively, and sub
• $805 b — dicaid expenditures of $944 billion and $805 billion, respectively, and subtracting pr
• $623 billion — e and Medicaid hospital expenditures of $623 billion and adding projected total pharmacy exp
• $225 billion — and Medicaid pharmacy expenditures, of $225 billion. The Companys platform is purpose-built

Filing Documents

• d251968ds1a.htm (S-1/A) — 3984KB
• d251968dex51.htm (EX-5.1) — 7KB
• d251968dex52.htm (EX-5.2) — 16KB
• d251968dex1023.htm (EX-10.23) — 26KB
• d251968dex1025.htm (EX-10.25) — 26KB
• d251968dex231.htm (EX-23.1) — 1KB
• g251968g01g00.jpg (GRAPHIC) — 461KB
• g251968g02t98.jpg (GRAPHIC) — 134KB
• g251968g03g03.jpg (GRAPHIC) — 113KB
• g251968g14g14.jpg (GRAPHIC) — 99KB
• g251968g70c01.jpg (GRAPHIC) — 64KB
• g251968g70c02.jpg (GRAPHIC) — 71KB
• g251968g70c03.jpg (GRAPHIC) — 58KB
• g251968g70c04.jpg (GRAPHIC) — 80KB
• 0001193125-24-015164.txt (&nbsp;) — 5537KB

Forward-Looking Statements

Forward-Looking Statements 83

Use of Proceeds

Use of Proceeds 86 Dividend Policy 87 Capitalization 88

Managements Discussion and Analysis of Financial Condition and Results

Managements Discussion and Analysis of Financial Condition and Results of Operations 92

Business

Business 136 Management 176

Executive Compensation

Executive Compensation 182 Certain Relationships and Related Party Transactions 205 Principal Stockholders 209 Tangible Equity Units Offering 211

Description of Capital Stock

Description of Capital Stock 213 Description of Certain Indebtedness 221 Shares Eligible for Future Sale 225 Material U.S. Federal Income Tax Consequences to Non-U.S. Holders 227 Underwriting (Conflicts Of Interest) 230 Legal Matters 238 Experts 238 Where You Can Find More Information 238 Index to Financial Statements F-1 Through and including the 25th day after the date of this prospectus, all dealers that effect transactions in these shares of our common stock, whether or not participating in this offering, may be required to deliver a prospectus. This is in addition to the dealers obligations to deliver a prospectus when acting as underwriters and with respect to their unsold allotments or subscriptions. You should rely only on the information contained in this prospectus or in any free writing prospectus we may authorize to be delivered or made available to you. Neither we nor the underwriters have authorized anyone to provide you with different information. The information in this prospectus is accurate only as of the date of this prospectus, regardless of the time of delivery of this prospectus, or any free writing prospectus, as the case may be, or any sale of shares of our common stock. For investors outside the United States: we are offering to sell, and seeking offers to buy, shares of our common stock only in jurisdictions where offers and sales are permitted. Neither we nor the underwriters have done anything that would permit this offering or possession or distribution of this prospectus in any jurisdiction where action for that purpose is required, other than in the United States. Persons outside the United States who come into possession of this prospectus must inform themselves about, and observe any restrictions relating to, the offering of the shares of common stock and the distribution of this prospectus outside the United States. i Table of Contents INDUSTRY AND MARKET DATA Within this prospectus, w

View Full Filing

View this S-1/A filing on SEC EDGAR